2025/05/22

CIC bioGUNE Management Team visits FAES Farma’s new production plant in Derio

Following the recent visit of the Development and Innovation Management team from FAES Farma to CIC bioGUNE, a delegation from the center - composed of General Director José M. Mato and Scientific Director Jesús Jiménez-Barbero - has made an institutional visit to the new production facilities recently inaugurated by the pharmaceutical company FAES Farma in Derio (Bizkaia).

This meeting marks another step forward in strengthening the collaboration between two key institutions in the fields of biomedical research and pharmaceutical innovation in the region. During the visit, CIC bioGUNE representatives were welcomed by FAES Farma’s management team, who provided a comprehensive tour of the new facilities, highlighting their technological capabilities, production processes, and quality control systems.

FAES Farma’s new plant reflects the company’s strong commitment to excellence and continuous innovation. With state-of-the-art infrastructure, the facilities align with the company’s strategy to expand production capacity and reinforce its efforts in developing new therapeutic solutions to address global health challenges.

Throughout the visit, both organizations reaffirmed their shared commitment to close collaboration, promoting knowledge transfer, and accelerating the development of new treatments. The discussions held during the visit allowed the teams to explore potential areas for future cooperation, with the common goal of addressing major health issues through science and innovation.

This reciprocal visit further consolidates the relationship between CIC bioGUNE, member of the BRTA, and FAES Farma, underscoring the strategic importance of public-private collaboration in building an innovative, competitive, and socially committed biomedical ecosystem.

About FAES Farma

FAES Farma is a Basque pharmaceutical company with more than 85 years of experience, dedicated to the research, development, production and marketing of products in various therapeutic areas. Founded in 1933, it has a solid track record in the creation of innovative pharmacological solutions, committed to health and scientific progress, and with a vision of the future focused on the continuous improvement of its products and services.

About CIC bioGUNE

The Centre for Cooperative Research in Biosciences (CIC bioGUNE), member of the Basque Research & Technology Alliance (BRTA), located in the Bizkaia Technology Park, is a biomedical research organization conducting cutting-edge research at the interface between structural, chemical, molecular and cell biology, with a particular focus on generating knowledge on the molecular bases of disease, for use in the development of new diagnostic methods and advanced therapies.

About BRTA

BRTA is an alliance of 4 collaborative research centres (CIC bioGUNE, CIC nanoGUNE, CIC biomaGUNE y CIC energiGUNE) and 13 technology centres (Azterlan, Azti, Ceit, Cidetec, Gaiker, Ideko, Ikerlan, Leartiker, Lortek, Neiker, Tecnalia, Tekniker y Vicomtech) with the main objective of developing advanced technological solutions for the Basque corporate fabric.

With the support of the Basque Government, the SPRI Group and the Provincial Councils of the three territories, the alliance seeks to promote collaboration between the research centres, strengthen the conditions to generate and transfer knowledge to companies, contributing to their competitiveness and outspreading the Basque scientific-technological capacity abroad.

BRTA has a workforce of over 4,000 professionals, executes 22% of the Basque Country's R&D investment, registers an annual turnover of more than 300 million euros and generates 100 European and international patents per year.

Spanish version